Followers | 813 |
Posts | 71326 |
Boards Moderated | 2 |
Alias Born | 01/30/2003 |
Wednesday, July 01, 2015 9:57:41 PM
$TPIV recent news/filings
## source: finance.yahoo.com
Thu, 25 Jun 2015 15:42:00 GMT ~ The Wealthy Biotech Trader's New Feature Pick Runs Over 150% After Announcement - Traders are Calling it the Next PPCH 3,200%+ Runner
[Accesswire] - WINDSOR, ON / ACCESSWIRE / June 25, 2015 / The Wealthy Biotech Trader (or "WBT") , an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, ...
read full: http://finance.yahoo.com/news/wealthy-biotech-traders-feature-pick-154200239.html
*********************************************************
Thu, 25 Jun 2015 12:32:00 GMT ~ No Negative Impact From A Strong Dollar With Small Cap Stocks
[Accesswire] - CORAL GABLES, FL / ACCESSWIRE / June 25, 2015 / Many companies and their publicly traded stock have been hurt this year by the stronger dollar. Even gold prices have shuttered as the US currency has gained ...
read full: http://finance.yahoo.com/news/no-negative-impact-strong-dollar-123200018.html
*********************************************************
Tue, 23 Jun 2015 15:24:06 GMT ~ TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients
[at noodls] - 23 Jun Phase I Trial analyses shows safety and positive immune response data SEATTLE, June 23, 2015 /PRNewswire/ - TapImmune Inc. (TPIV) is pleased to report the completion of data analysis from patients ...
read full: http://www.noodls.com/view/CDC906F9FC63EFC056C8805122CE5D1ED7F63A51
*********************************************************
Tue, 23 Jun 2015 12:30:00 GMT ~ TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients
[PR Newswire] - SEATTLE, June 23, 2015 /PRNewswire/ -- TapImmune Inc . (OTQB: TPIV) is pleased to report the completion of data analysis from patients treated in a Phase I clinical trial. In this Phase 1 trial conducted ...
read full: http://finance.yahoo.com/news/tapimmune-reports-robust-immune-responses-123000706.html
*********************************************************
Fri, 19 Jun 2015 15:38:07 GMT ~ TAPIMMUNE INC Files SEC form 8-K, Unregistered Sale of Equity Securities
read full: http://biz.yahoo.com/e/150619/tpiv8-k.html
*********************************************************
$TPIV charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TPIV company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TPIV/company-info
Ticker: $TPIV
OTC Market Place: OTCQB
CIK code: 0001094038
Company name: TapImmune, Inc.
Company website: http://www.tapimmune.com
Incorporated In: NV, USA
Business Description: Cancer and viral disease immunotherapy products R&D company
$TPIV share structure
## source: otcmarkets.com
Market Value: $31,333,259 a/o Jun 30, 2015
Shares Outstanding: 32,638,811 a/o May 15, 2015
Float: 26,744,609 a/o May 01, 2015
Authorized Shares: 500,000,000 a/o May 01, 2015
Par Value: Not Available
$TPIV extra dd links
Company name: TapImmune, Inc.
Company website: http://www.tapimmune.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TPIV+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TPIV+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TPIV+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/news - http://finance.yahoo.com/q/h?s=TPIV+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TPIV/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TPIV+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TPIV
DTCC (dtcc.com): http://search2.dtcc.com/?q=TapImmune%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TapImmune%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TapImmune%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.tapimmune.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.tapimmune.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.tapimmune.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TPIV
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001094038&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TPIV&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TPIV
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TPIV+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TPIV+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TPIV
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TPIV
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TPIV+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TPIV/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TPIV+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TPIV.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TPIV
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TPIV/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TPIV/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TPIV
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TPIV
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TPIV:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TPIV
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TPIV
$TPIV DD Notes ~ http://www.ddnotesmaker.com/TPIV
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.